Would you offer liver SBRT to a patient with a history of a liver transplant?

At the University of Michigan, we have offered SBRT for patients who have failed intrahepatically post liver transplant with no metastatic disease. The risk of relapse of HCC post transplant is 15-20%. There is an interesting score developed by UCSF (RETREAT; Mehta et al., JAMA Onc 2016) in which th...